Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of recombinant human Neuregulin in chronic systolic heart failure
CTR20171582Phase 3Active
- Sponsor
- Zensun
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in heart failure with reduced ejection fraction (HFrEF), sponsored by Zensun. Started Jul 2018; status: active.
02
Drugs
neucardin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on CTR20171582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171582.